Phillip A. Sharp, Director: Alnylam Pharmaceuticals ALNY Sell · Filed 24/03/01

Trade details

Type: Insider sale
Amount: $2,052,936.51
Shares · price: 13,557 sh · $151.43 a share
Held after: 3,438 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Phillip A. SharpDirector
Trade date: 24/02/29
Filed: 24/03/01
Days to filing: 1 days

Sold 79.8% of holdings

Share of holding sold: 79.8%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/30~24/03/30

Phillip A. Sharp's recent trades

Phillip A. SharpDirector
Planned sale10b5-1 planAlnylam Pharmaceuticals
Planned sale10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$3.4M
11,250 sh
$3.4M
Filed 25/05/30
Traded 25/05/30
Phillip A. SharpDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$3.1M
11,250 sh
$3.1M
Filed 25/01/24
Traded 25/01/23
Phillip A. SharpDirector
Planned sale10b5-1 planAlnylam Pharmaceuticals
Planned sale10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$3.1M
11,250 sh
$3.1M
Filed 25/01/23
Traded 25/01/23
Phillip A. SharpDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$2M
13,005 sh
$2M
Filed 24/03/01
Traded 24/02/29
Phillip A. SharpDirector
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$292.8K
1,906 sh
$292.8K
Filed 24/03/01
Traded 24/02/29

Phillip A. Sharp, Director — sold $2.1M of Alnylam Pharmaceuticals ALNY · 79.8% of holdings · 10b5-1 plan | Whalegun